NEWS RELEASE UNDER EMBARGO UNTIL AUGUST 27, 2025, 12:01 AM ET Media contact: Freya Weise, MD, PhD Elsevier +33 (1) 71 16 55 00 hmsmedia@elsevier.com Research in the Journal of Hepatology shows that assessing the moderating effects of two important lifestyle behaviors on liver mortality risk offer…
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative medicine. He serve…
This paper is more than a review: it is a consensus report by a group of 34 leading international experts in hepatology, data science, and artificial intelligence, presenting concrete recommendations…
EASL joins the global hepatology community in mourning the passing of Professor Jaime Bosch, an exceptional clinician-scientist, educator and leader whose career has shaped the field of hepatology for over five decades. Born in Girona, Catalonia, on 10 August 1947, Professor Bosch graduated top o…
EASL has released its new Equity, Diversity, and Inclusion (EDI) Policy Statement and invites feedback. Built around the association’s four pillars: Education, Advocacy, Science, and Leadership, the statement reflects EASL’s commitment to creating an inclusive environment across all areas of its …
EASL is proud to announce that both of its journals have achieved outstanding new impact factors, as released in the 2025 Journal Citation Reports (JCR) by ClarivateTM. The Journal of Hepatology, EASL’s flagship publication, has reached a record-high Impact Factor of 33.0, reinforcing its status …
Barbora Smolkova, PhD, is a doctoral researcher at the Department of Paediatric Research at Oslo University Hospital, where she focuses on the cellular mechanisms of genetic liver diseases. Her work, which combines stem cell technologies and liver organoid models, recently earned her the prestigi…
EASL has published its Clinical Practice Guidelines on abdominal extrahepatic surgery in cirrhosis and advanced chronic liver disease. These guidelines represent a critical step forward in improving outcomes for a growing and vulnerable patient population. Addressing a complex clinical challenge …
EASL has released its newly updated Clinical Practice Guidelines (CPGs) on Autoimmune Hepatitis (AIH), bringing substantial revisions to the previous 2015 edition. Developed through a structured approach using PICO questions and a two-round Delphi panel process, the 2025 guidelines reflect recent…
EASL has released new Clinical Practice Guidelines (CPGs) for the management of extrahepatic cholangiocarcinoma (eCCA). These guidelines offer an updated, clinically oriented resource to support healthcare professionals in the accurate diagnosis and management of this malignancy. Developed using …
